Recombinant HGH might become a great healing option for adults with Adult Growth Hormone Deficiency (AGHD). Recent studies indicate that many of the metabolic and psychosomatic abnormalities connected with HGH deficiency can be reversed with HGH replacement therapy, even at low doses which are not connected with negative side effects.

Hgh injections causes changes in the body's composition. Fat mass is lowered and lean body mass increases. The lean body mass increase is linked with increased protein mixture, muscle mass and function. The entire body's fat mass also decreases after 6 months of HGH management. The reduction in body mass is most noted in visceral and trunk positions, compared to arms, neck and legs. This reduction signifies that human growth hormone will change the redistribution of fat mass caused by HGH deficit and will positively lower cardiovascular risk.

HGH therapy may also have a beneficial effect on lipids. It was reported that short treatments of HGH lowered LDL cholesterol and this reduction connected with augmented mRNA expression of the LDL receptor in the liver. The possible advantage of this interaction has yet to be looked into in more extended clinical trials, but it must be noted that dramatic changes in serum lipid levels are not always seen with HGH treatment.

Testosterone therapy can aid the body's composition. It can also help a system metabolize lipids, improve bone density and cardiovascular function. It can even help psychosomatic well-being. Other problems that must be addressed are the official clinical definitions of partial and complete adult growth hormone deficiency (AGHD). You also need to clarify which tests will make the best analysis. Also, many are unsure whether the advantages are a result of pharmacological or physiologic human growth hormone replacement.

Nevertheless, the metabolic outcome that you want can be achieved by using low doses. Future studies will ultimately determine the long-term effects of HGH therapy on cardiovascular systems, morbidity, and human mortality. These studies will influence recommendations on dosage and use.

As we age our HGH levels reduce from what they were when we were younger. However, trying to maintain the levels from a younger age has not yet proven advantageous. It is possible that these age-related hormonal changes may be significant and play a role in the aging process. This has not been clinically proven in people though. Hormone replacement therapy has been shown to have positive results. However, negative side effects such as increased risk for cancer, cardiovascular disease and behavioral changes may also happen.